Caribou Biosciences, Inc.
CRBU
$0.735
$0.00190.26%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -35.49M | -34.68M | -37.70M | -41.23M | -34.51M |
| Total Depreciation and Amortization | 1.18M | 1.18M | 856.00K | 710.00K | 740.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.14M | 3.67M | 1.11M | 4.17M | 7.36M |
| Change in Net Operating Assets | -4.30M | -2.82M | 2.86M | -849.00K | 5.02M |
| Cash from Operations | -35.47M | -32.66M | -32.87M | -37.20M | -21.38M |
| Capital Expenditure | -518.00K | -673.00K | -2.24M | -1.45M | -2.28M |
| Sale of Property, Plant, and Equipment | 13.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 16.44M | 27.19M | 23.44M | 24.40M | -29.20M |
| Cash from Investing | 15.93M | 26.52M | 21.20M | 22.96M | -31.47M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.86M | 244.00K | 132.00K | 12.49M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -43.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3.86M | 244.00K | 132.00K | 12.49M | -43.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -15.68M | -5.90M | -11.53M | -1.76M | -52.90M |